SRH Advisors’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

SRH Advisors’s Portfolio ALXA Stock Details ALXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,350	Closed	-$2K	–	250
2016 Q1	$2K	Hold	4,350	–	–	0.01%	213
2015 Q4	$3K	Hold	4,350	–	–	0.02%	160
2015 Q3	$5K	Hold	4,350	–	–	0.03%	141
2015 Q2	$5K	Hold	4,350	–	–	0.03%	142
2015 Q1	$9K	Hold	4,350	–	–	0.06%	107
2014 Q4	$6K	Buy	4,350 +4,000	+1,143%	+$7.14K	0.04%	127
2014 Q3	$1K	Hold	350	–	–	0.01%	246
2014 Q2	$2K	Hold	350	–	–	0.02%	139
2014 Q1	$2K	Hold	350	–	–	0.02%	138
2013 Q4	$2K	Buy	+350	New	+$1.72K	0.02%	141

SRH Advisors's ALXA Position: Q2 2016 in Review

SRH Advisors sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 4,350 shares — an estimated $2K sold.

SRH Advisors first reported a position in ALXA in Q4 2013 and held it in 10 quarters. The position peaked at $9K in Q1 2015. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.

SRH Advisors reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
SRH Advisors sold 4,350 Alexza Pharmaceuticals Inc shares in Q2 2016, an estimated $2K.
SRH Advisors first reported a position in Alexza Pharmaceuticals Inc in Q4 2013 and held it in 10 quarters.
SRH Advisors's Alexza Pharmaceuticals Inc position peaked at $9K in Q1 2015.
0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.

Based on SRH Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.